Real world data analysis in clinical trials is the practical work of using healthcare data collected outside a study protocol to answer defined clinical, operational, or strategic questions. In this explainer, we break down the difference between real world data and real world evidence, where these data sources come from, and why they are increasingly used alongside controlled trial data to extend follow-up, broaden population context, and understand what happens in routine care.
You’ll learn where real world data fits around a trial, including feasibility and population planning before a study starts, contextual understanding during development, and longer-term safety or outcome follow-up after formal trial observation ends. We also explain why this work is not just about access to larger datasets, but about choosing data that are fit for purpose, defining clear questions up front, and applying methods that are transparent and defensible.
We walk through practical considerations teams need to get right:
• Choosing data sources based on the decision being supported
• Understanding the trade-offs between EHRs, claims, registries, lab data, and patient-generated data
• Reconstructing patient timelines from fragmented records across multiple tables and systems
• Defining cohorts, exposures, endpoints, and edge cases consistently and traceably
• Managing limitations such as confounding, missingness, representativeness, privacy, and governance
Finally, we address common misunderstandings, such as treating real world data as a substitute for trial data, or treating observational findings as if they provide randomised proof. In practice, the value depends on careful study design, disciplined analysis, and clear documentation of assumptions and limitations.
At Quanticate, our biometrics teams support sponsors with real world data analysis that is scientifically grounded, transparent, and aligned with the realities of regulated development. Request a consultation today.